If they are getting good enough signals to allow AKIDA to pick up a pending seizure one hour before then it stands to reason it will pick up any other brain signal abnormality.
It just needs trials with individuals that have the target condition to identify what signals need to be monitored.
The beauty of AKIDA technology is that it can be scaled to allow the detection of multiple conditions should it become necessary rather than requiring an individual to wear multiple detection devices.
My opinion only DYOR
Fact Finder
BRN Price at posting:
22.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)